KEGG   DRUG: Pneumococcal 15-valent conjugate vaccine
Entry
D12205                      Drug                                   

Name
Pneumococcal 15-valent conjugate vaccine;
Vaxneuvance (TN)
Product
Class
Other
 DG01686  Inactivated vaccine
Remark
ATC code: J07AL02
Product: D12205<US>
Efficacy
Active immunization (pneumococcal)
  Disease
Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F [DS:H01321]
Comment
Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AL Pneumococcal vaccines
     J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
      D12205  Pneumococcal 15-valent conjugate vaccine <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12205
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12205
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system